BeOne Medicines Ltd. - Ordinary shares, par value $0.0001 per share (ONC)

Q: What does CUSIP 07725L102 represent in this 13F holders report?

CUSIP 07725L102 is the security identifier for ONC - BeOne Medicines Ltd. - Ordinary shares, par value $0.0001 per share used to aggregate holder disclosures.

Q: How many institutions held ONC - BeOne Medicines Ltd. - Ordinary shares, par value $0.0001 per share in Q4 2021?

247 institutional investors reported ONC - BeOne Medicines Ltd. - Ordinary shares, par value $0.0001 per share for Q4 2021. Use the holders table for investor-level position and value details.

CUSIP: 07725L102

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class: Equity / Ordinary shares, par value $0.0001 per share
Shares outstanding: 1,385,160,313
Total 13F shares: 55,475,829
Share change: -850,922
Total reported value: $15,026,076,469
Put/Call ratio: 440%
Price per share: $270.93
Number of holders: 247
Value change: -$242,691,110
Number of buys: 110
Number of sells: 122

Quarterly Holders Quick Answers

What is CUSIP 07725L102?
CUSIP 07725L102 identifies ONC - BeOne Medicines Ltd. - Ordinary shares, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2022
Previous quarter: Q3 2021

Recent filing periods for CUSIP 07725L102:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of ONC - BeOne Medicines Ltd. - Ordinary shares, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BAKER BROS. ADVISORS LP	13F	Company	0.84%	11,668,897	$4,235,810,000	—	30 Sep 2021	13F
AMGEN INC	3/4/5	10%+ Owner	— class O/S missing	18,943,802	$3,419,356,261	—	10 Sep 2021	3/4/5
Capital International Investors	13F	Company	0.46%	6,323,919	$2,295,118,000	—	30 Sep 2021	13F
HHLR ADVISORS, LTD.	13F	Company	0.4%	5,472,259	$1,986,430,000	—	30 Sep 2021	13F
BAILLIE GIFFORD & CO	13F	Company	0.31%	4,249,052	$1,542,406,000	—	30 Sep 2021	13F
FMR LLC	13F	Company	0.28%	3,812,000	$1,383,755,000	—	30 Sep 2021	13F
PRIMECAP MANAGEMENT CO/CA/	13F	Company	0.28%	3,811,347	$1,383,519,000	—	30 Sep 2021	13F
Invesco Ltd.	13F	Company	0.22%	3,060,292	$1,110,886,000	—	30 Sep 2021	13F
Temasek Holdings (Private) Ltd	13F	Company	0.21%	2,914,313	$1,057,896,000	—	30 Sep 2021	13F
BlackRock Finance, Inc.	13F	Company	0.19%	2,629,542	$954,524,000	—	30 Sep 2021	13F
Capital International, Inc./CA/	13F	Company	0.07%	1,012,135	$367,405,000	—	30 Sep 2021	13F
STATE STREET CORP	13F	Company	0.07%	905,082	$328,545,000	—	30 Sep 2021	13F
Howard Liang	3/4/5	CFO & Chief Strategy Officer	— class O/S missing	1,553,149	$322,615,606	—	28 Jun 2021	3/4/5
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	0.06%	850,803	$308,841,000	—	30 Sep 2021	13F
Boxer Capital, LLC	13F	Company	0.06%	764,188	$277,400,000	—	30 Sep 2021	13F
Artal Group S.A.	13F	Company	0.05%	650,000	$235,950,000	—	30 Sep 2021	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.04%	570,853	$207,220,000	—	30 Sep 2021	13F
PUBLIC INVESTMENT FUND	13F	Company	0.04%	495,389	$179,826,000	—	30 Sep 2021	13F
NORGES BANK	13F	Company	0.03%	346,341	$125,722,000	—	30 Sep 2021	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.02%	289,967	$105,258,000	—	30 Sep 2021	13F
Legal & General Group Plc	13F	Company	0.02%	248,405	$90,171,000	—	30 Sep 2021	13F
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC	13F	Company	0.02%	244,492	$88,751,000	—	30 Sep 2021	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.02%	217,547	$78,970,000	—	30 Sep 2021	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.01%	206,716	$74,530,000	—	30 Sep 2021	13F
USS Investment Management Ltd	13F	Company	0.01%	181,844	$66,074,000	—	30 Sep 2021	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.01%	180,624	$65,566,512	—	30 Sep 2021	13F
Bridgewater Associates, LP	13F	Company	0.01%	175,923	$63,860,000	—	30 Sep 2021	13F
JPMORGAN CHASE & CO	13F	Company	0.01%	172,496	$62,616,000	—	30 Sep 2021	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.01%	163,739	$59,437,000	—	30 Sep 2021	13F
Capital Group Private Client Services, Inc.	13F	Company	0.01%	161,980	$58,799,000	—	30 Sep 2021	13F
BNP Paribas Asset Management Holding S.A.	13F	Company	0.01%	156,925	$56,964,000	—	30 Sep 2021	13F
Casdin Capital, LLC	13F	Company	0.01%	150,000	$54,450,000	—	30 Sep 2021	13F
Mitsubishi UFJ Trust & Banking Corp	13F	Company	0.01%	145,483	$52,810,000	—	30 Sep 2021	13F
Fiera Capital Corp	13F	Company	0.01%	145,239	$52,722,000	—	30 Sep 2021	13F
S.c.a. Candriam	13F	Individual	0.01%	136,281	$49,468,000	—	30 Sep 2021	13F
Mirae Asset Global Investments Co., Ltd.	13F	Company	0.01%	136,274	$49,468,000	—	30 Sep 2021	13F
MORGAN STANLEY	13F	Company	0.01%	127,924	$46,436,000	—	30 Sep 2021	13F
NORTHERN TRUST CORP	13F	Company	0.01%	122,680	$44,532,000	—	30 Sep 2021	13F
MACQUARIE GROUP LTD	13F	Company	0.01%	117,170	$42,533,000	—	30 Sep 2021	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.01%	115,436	$41,903,000	—	30 Sep 2021	13F
Swiss National Bank	13F	Company	0.01%	112,985	$41,014,000	—	30 Sep 2021	13F
PARTNERS CAPITAL INVESTMENT GROUP, LLP	13F	Company	0.01%	112,146	$40,709,000	—	30 Sep 2021	13F
Sumitomo Mitsui Trust Group, Inc.	13F	Company	0.01%	110,626	$40,157,000	—	30 Sep 2021	13F
DEUTSCHE BANK AG\	13F	Company	0.01%	110,440	$40,088,000	—	30 Sep 2021	13F
Capital International Sarl	13F	Company	0.01%	105,337	$38,237,000	—	30 Sep 2021	13F
Amundi	13F	Individual	0.01%	94,831	$34,424,000	—	30 Sep 2021	13F
CREDIT SUISSE AG/	13F	Company	0.01%	92,914	$33,728,000	—	30 Sep 2021	13F
Jane Huang	3/4/5	CMO, Hematology	— mixed-class rows	371,331 mixed-class rows	$33,246,160	—	14 Dec 2021	3/4/5
UBS Group AG	13F	Company	0.01%	86,578	$31,428,000	—	30 Sep 2021	13F
VANGUARD GROUP INC	13F	Company	0.01%	85,361	$30,986,000	—	30 Sep 2021	13F

Institutional Holders of BeOne Medicines Ltd. - Ordinary shares, par value $0.0001 per share (ONC) as of Q4 2021

As of 31 Dec 2021, BeOne Medicines Ltd. - Ordinary shares, par value $0.0001 per share (ONC) was held by 247 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 55,475,829 shares. The largest 10 holders included BAKER BROS. ADVISORS LP, Capital International Investors, HHLR ADVISORS, LTD., BAILLIE GIFFORD & CO, PRIMECAP MANAGEMENT CO/CA/, FMR LLC, Invesco Ltd., Temasek Holdings (Private) Ltd, BlackRock Inc., and CAPITAL INTERNATIONAL INC /CA/. This page lists 249 institutional shareholders reporting positions in this security for the Q4 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2021 vs Q3 2021 Across Filers

Q3 2021 holders

242

Q4 2021 holders

247

Holder diff

Investor	Q3 2021 Shares	Q4 2021 Shares	Share Diff	Share Chg %	Q3 2021 Value $	Q4 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.